Invivyd's average Accounts Receivable for the
three
months ended in Dec. 2024 was $9.53 Mil. Invivyd's Revenue for the
three
months ended in Dec. 2024 was $13.82 Mil.
Hence, Invivyd's Days Sales Outstanding for the
three
months ended in Dec. 2024 was 62.92.
The historical rank and industry rank for Invivyd's Days Sales Outstanding or its related term are showing as below:
IVVD'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 105.2 Med: 156.82 Max: 156.82
Current: 105.2
During the past 5 years, Invivyd's highest Days Sales Outstanding was 156.82. The lowest was 105.20. And the median was 156.82.
IVVD's Days Sales Outstanding is ranked worse than 68.97% of 854
companies
in the Biotechnology industry
Industry Median: 72.935
vs IVVD: 105.20
Invivyd's Days Sales Outstanding
increased
from Dec. 2023 (0.00) to Dec. 2024 (62.92).
Invivyd Days Sales Outstanding Historical Data
The historical data trend for Invivyd's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Invivyd's Days Sales Outstanding
For the Biotechnology subindustry, Invivyd's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invivyd's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Invivyd's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Invivyd's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invivyd (NAS:IVVD) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Invivyd Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Invivyd's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IVVD has been successfully added to your 